Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA ...Middle East

Ixekizumab has taken a major step toward its approval for the treatment of psoriatic arthritis and enthesitis-related arthritis in children, based on positive data from a phase 3 trial. Medscape Medical News

Hence then, the article about phase 3 trial supports ixekizumab in juvenile psa era was published today ( Thursday 20/06/2024 - 11:52 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA )

Also on site :

• Cherie DeVaux se convierte en la primera entrenadora en ganar el Derby de Kentucky con la histórica victoria de Golden Tempo
• Beloved ’80s Actor and Brother of Popular Newscaster Turns 80
• OPEC+ makes first output decision after UAE exit – Reuters